Colgate-Palmolive is set to announce its third-quarter 2025 earnings, drawing market attention after previously exceeding ...
The DeSantis administration is warning nearly 3 million Floridians who rely on federal food assistance that their benefits ...
Coach Cassie Wiseman is in her third year as Taylor’s head coach.. She has created a theme with her team of 10 to 1, climbing ...
In light of the federal shutdown and the threat it poses to critical programs like the Supplemental Nutrition Assistance ...
CL shares are down after reporting Q3 results, but expect growth thanks to new strategy and strong market share. Keep an eye ...
1hon MSNOpinion
Ex-Louisville basketball star DeJuan Wheat channels Denny Crum in first head-coaching job
This episode features DeJuan Wheat reflecting on his storied past with the Cardinals while trying to shape the future with ...
TipRanks on MSN
Colgate-Palmolive Launches Strategic Growth Program
An update from Colgate-Palmolive ( ($CL) ) is now available. On July 31, 2025, Colgate-Palmolive‘s Board of Directors approved a new three-year ...
The consumer products giant reported third-quarter adjusted earnings per share of 91 cents, beating the analyst consensus estimate of 89 cents. Quarterly sales of $5.131 billion were in line with the ...
Restore Robotics Surpasses 300 Hospitals in Robotic Instrument Recycling and Remanufacturing Program
HENDERSON, Nev., Oct. 14, 2025 /PRNewswire/ -- Restore Robotics announced today that more than 300 hospitals and surgery centers across the United States have joined its growing recycling and ...
AKRON, Ohio, Oct. 21, 2025 /PRNewswire/ -- Smithers Quality Assessments Division has achieved first place in the International Automotive Oversight Bureau's (IAOB) External Balanced Scorecard (EBSC) ...
Adjusted EBITDA 1 increased by over $17 million compared to the prior quarter and by almost $11 million on a year-over-year basis despite continued elevated raw material costs. Total adjusted EBITDA ...
Boehringer awarded FDA Commissioner's National Priority Voucher for HERNEXEOS(R) in HER2 lung cancer
Boehringer recently reported positive results from the Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced NSCLC at ESMO 2025. The company is pursuing regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results